Delivery Order SPE2DB20D3505-SPE2DB25FYCCD
Award Date 9/2/25
Potential Completion Date 9/3/25
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $78,825.44. The contract is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 26, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $7,025.59. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 29, 2025. The contract represents a child delivery order under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $10,324.90. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a single transaction under the company's broader pharmaceutical supply relationship with DLA. The award was not designated as a set-aside contract and was competitively awarded. Performance of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on June 17, 2025, with a ceiling value of $9,037.92. The contract, which is a child award under a larger indefinite delivery contract (IDC), covers the supply of Otezla 30 mg tablets in quantities of 60 units. The award was made through open competition with no set-aside designation, and the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a contract ceiling value of $9,461.61. This firm fixed-price delivery order, which is not set-aside, is expected to be completed by November 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,235.58 by the Defense Logistics Agency for 60 tablets of Otezla 30 mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitive award utilized firm fixed pricing with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) with a ceiling value of $27,320.78. This firm fixed-price delivery order, which is expected to be completed by July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $7,386.55 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,467.94 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on January 26, 2026, with an ultimate completion date of January 27, 2026. This firm fixed-price, non-set-aside award represents a child contract under AmerisourceBergen's parent company, Cencora, Inc. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $19,860.97 delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on June 26, 2025, with completion expected by June 27, 2025. This firm fixed-price contract represents a non-competitive set-aside and reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs. The order is being performed at the contractor's corporate office location in...